Evidence map›Paper›PMID 24509632›Full record

ArticleNature methods2014

Isolation of single-base genome-edited human iPS cells without antibiotic selection.

Yuichiro Miyaoka, Amanda H Chan, Luke M Judge, Jennie Yoo, Miller Huang, Trieu D Nguyen, Paweena P Lizarraga, Po-Lin So, Bruce R Conklin

Open access · greenAbstract read
In one paragraph

Article in Nature methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed
11.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 334 citations in OpenAlex.

  1. TDP-43 dysfunction induces cryptic circular RNAs in ALS/FTD.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The MIRO1-BAX Complex Dictates Life and Death at the Mitochondrial Gate.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Arrayed dual-gRNA CRISPR screening platform forMolecular therapy. Advances · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Haplotype editing with CRISPR-Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuichiro MiyaokaGladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
Amanda H ChanGladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
Luke M Judge1] Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA. [2] Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
Jennie YooGladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
Miller HuangDepartment of Neurology, University of California San Francisco, San Francisco, California, USA.
Trieu D NguyenGladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
Paweena P LizarragaGladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
Po-Lin SoGladstone Institute of Cardiovascular Disease, San Francisco, California, USA.
Bruce R Conklin1] Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA. [2] Department of Medicine, University of California San Francisco, San Francisco, California, USA. [3] Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.
Gladstone Institutes · USUniversity of California, San Francisco · US

Funding

Transcriptional Networks During Cardiac DifferentiationP01HL089707 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI BLACK, BRIAN L · 2008 to 2017
$20.4M
The Epigenetic Landscape of Heart DevelopmentU01HL098179 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI BOYER, LAURIE A, BRUNEAU, BENOIT GAETAN · 2009 to 2014
$10.0M
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart DiseasU01HL100406 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI BRUNEAU, BENOIT GAETAN, CONKLIN, BRUCE R · 2009 to 2015
$9.4M
Tissue Engineering with a Modular RASSL ToolboxR01HL060664 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 1998 to 2012
$7.0M
Structures of Protein Complexes Regulating Transcription in Enbryonic Stem CellsU01GM094614 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WEBB, PAUL · 2010 to 2014
$5.7M
Disease Specific Cardiac Tissue ModelsR01HL108677 · NHLBI · UNIVERSITY OF CALIFORNIA BERKELEY · PI CONKLIN, BRUCE R, HEALY, KEVIN EDWARD · 2011 to 2014
$2.4M
COLLABORATIVE R01--ROLES OF G PROTEINS IN CARDIOMYOPATHYR01HL061689 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI CONKLIN, BRUCE R · 1998 to 2002
$1.2M
PHARMACOLOGY AND PHYSIOLOGY IN BIOMEDICAL RESEARCHF31GM009614 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI MUNGER, KAREN · 1985 to 1988
–
NHLBI NIH HHS P01 HL089707NHLBI NIH HHS R01 HL060664NHLBI NIH HHS R01-HL060664NHLBI NIH HHS R01 HL061689NHLBI NIH HHS R01 HL108677NHLBI NIH HHS R01-HL108677NHLBI NIH HHS U01 HL098179NHLBI NIH HHS U01-HL098179NHLBI NIH HHS U01 HL100406NHLBI NIH HHS U01-HL100406NIGMS NIH HHS U01 GM094614NIGMS NIH HHS U01-GM09614
6 · The paper itself

Abstract

Precise editing of human genomes in pluripotent stem cells by homology-driven repair of targeted nuclease-induced cleavage has been hindered by the difficulty of isolating rare clones. We developed an efficient method to capture rare mutational events, enabling isolation of mutant lines with single-base substitutions without antibiotic selection. This method facilitates efficient induction or reversion of mutations associated with human disease in isogenic human induced pluripotent stem cells.

Indexed as

Genome, HumanAnti-Bacterial AgentsBase CompositionCell LineCloning, MolecularCytological TechniquesHumansInduced Pluripotent Stem CellsMutationAnti-Bacterial Agents

Identifiers

PMID24509632
PMCPMC4063274
OpenAlexW2003418092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.